Welcome to the Frank C. and Lynn Scaduto MIND Institute
Memory Disorder Clinic and Clinical Research Site Specializing in Alzheimer’s Disease
MIND Institute at Miami Jewish Health is a memory disorder clinic that offers diagnosis and treatment for a variety of neurocognitive disorders such as Alzheimer’s disease, dementia, and mild cognitive impairment. We also specialize in clinical research of new medications and emerging treatments for Alzheimer’s disease, agitation symptoms and major depressive disorder. Schedule a visit today to explore your care options or eligibility for a clinical trial.
What We Do as a State-Designated Memory Disorder Clinic
At MIND Institute, our state-designation as one of only 17 memory disorder clinics in Florida empowers us to lead with innovation and compassion in the fight against Alzheimer’s disease and related dementia. To serve older adults and their caregivers throughout Miami-Dade, we are specially authorized by the state to:
- Provide comprehensive evaluation, treatment and referral services for people experiencing symptoms of neurocognitive decline
- Conduct clinical research on new Alzheimer’s disease treatments
- Develop training materials and educational opportunities for dementia caregivers
Alzheimer’s Disease on the Rise
Dementia Treatment Programs
One of the things that distinguishes us as a memory disorder clinic is our approach to patient-centered care. We believe that people with Alzheimer’s disease, memory changes, and other neurocognitive conditions can continue to live with purpose and joy. Our programs are built on that belief.
Guiding an Improved Dementia Experience (GUIDE) Program
The GUIDE program takes a comprehensive and coordinated approach that helps both the patient and their unpaid caregivers. The goal is to improve quality of life for people with dementia, enabling them to remain in their homes and communities. This is a Medicare-funded program that provides care coordination, care management, caregiver education and support, and respite services. Learn more about GUIDE.
Dementia Assessment & Care Planning
We provide outpatient assessment and disease management for individuals with either new neurocognitive changes or an established diagnosis of Alzheimer’s disease, or related dementia. We emphasize the unique needs of each patient and deliver individualized therapeutic and social services.
Meaningful MINDs
This treatment program is well-suited for those in the early stages of Alzheimer’s disease, and those with mild to moderate cognitive impairment who recognize they need help and direction. We identify each participant’s strengths and challenges and provide personalized one-on-one activity sessions with a MIND coach to enhance nine key areas of cognition, mood, and behavior. Learn more about Meaningful MINDs.
Alzheimer’s Prevention Program
People concerned about neurocognitive changes can join this structured, evidence-based program to assess their risk factors for Alzheimer’s disease, benchmark their current neurocognitive health, and receive customized lifestyle coaching for improved brain fitness. Learn more about our Alzheimer’s Prevention Program.
Dementia Caregiver Support & Education
Helping family caregivers is a big focus at MIND Institute. We offer one-on-one counseling sessions, a caregiver support group, and extensive case management for those with greater need.
Clinical Trial Participation
Our memory disorder clinic is also a leading clinical research site for treatments under development. Participants must be diagnosed with mild to moderate Alzheimer’s disease, be aged 50-90+ and have an involved caregiver. See what clinical research trials are currently available.
Visionary Leadership with an EmpathiCareSM Approach
Dr. Marc E. Agronin
Dr. Marc E. Agronin, a board-certified adult and geriatric psychiatrist, serves as Chief Medical Officer for MIND Institute. His pioneering EmpathiCareSM philosophy delivers life-enhancing care to patients and families — from diagnosis and action-based therapy, to caregiver support and beyond. Read more about Dr. Agronin’s life-changing work.
Featured Podcast: The Journal of Clinical Psychiatry
Dr. Agronin discusses the latest breakthroughs in Alzheimer’s disease including biomarker-based diagnosis, anti-amyloid therapies, emerging research, and the importance of empathy and person-centered dementia care in this episode of The Journal of Clinical Psychiatry Podcast.
Alzheimer’s Disease Clinical Trials
MIND Institute is a leading clinical research site for the latest treatments for Alzheimer’s disease. Our clinical trials employ the latest methodologies and are guided by the most promising theories in the field. By joining our community of participants, you become a vital part of the journey to develop new medical treatments for Alzheimer’s disease that will change lives.
You or your loved one may be eligible to participate after meeting the following criteria:
- Individual has been diagnosed with mild to moderate Alzheimer’s disease
- Individual is age 50 to 90+
- Individual has an involved caregiver
How Our Memory Disorder Clinic Has Helped Patients & Families
Denise W.
"When my husband, Brian, was first diagnosed with Alzheimer's disease in September 2022 I felt lost and hopeless. We saw neurologists from several well-known institutions who gave us very little guidance and treated Brian like a number. After doing some research, I came across Dr Agronin. From our first encounter, he was kind and caring, had a warm attitude, and thought outside the box. He listened carefully to all of our concerns and provided a roadmap for not just Brian's care, but for mine as a caregiver. There is no way I could survive this journey without him."
Scott J.
"Thanks to Dr. Agronin's care and the therapy he prescribed, we were able to take Marcia to the Florida Panthers game tonight. It was something I never thought we could pull off. My family is forever grateful for your efforts."
Mary B.
"I felt like I was failing in life. I wanted to get my mind refocused, so my doctor recommended this place. I want to communicate better with people. A lot of people are content with staying the way they are, but I’m not. I know I’ll never get back to where I was, but I want to be close. That’s important to me. I want to stay focused and know what’s going on."
Ana K.
"I come here because I have a problem with my short-term memory. I read a lot, but I need to memorize more. When I work with the staff, they are very caring. This program saves people, not only because we have memory problems, but it also helps with isolation. Older people are very isolated, and they try to make us feel more enlightened."
Related Content
What to Expect During a Cognitive Screening
Annual cognitive screenings can play a vital role in detecting potential issues early, allowing for timely intervention and better outcomes for conditions like Alzheimer’s disease. In this post, we’ll walk you through what to expect during a cognitive screening, helping you feel more prepared and at ease with the process.
Dementia & Wandering: Tips to Keep Your Loved One Safe
Wandering is one of the most common and concerning behaviors associated with dementia. According to the Alzheimer’s Association, between 35% and 60% of people with dementia will wander at some point. However, wandering does not have to be an inevitable crisis. While it can create fear and stress for families, this challenging behavior can be managed with preparation and understanding.
The Seven Stages of Dementia
In this guide, we will walk through the seven stages of dementia to help you learn how symptoms may progress and how to navigate each step of the way.
Request More Information
We are here to help you and your family navigate the challenges of Alzheimer’s disease and dementia. Simply fill out the form below and a representative from our team will reach out to you to answer any questions about our memory disorder clinic and assist you with scheduling an appointment.
* indicates a required field